BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 216752)

  • 1. Activation of latent murine cytomegalovirus infection: cocultivation, cell transfer, and the effect of immunosuppression.
    Mayo D; Armstrong JA; Ho M
    J Infect Dis; 1978 Dec; 138(6):890-6. PubMed ID: 216752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of biological response modifiers on chronic and latent murine cytomegalovirus infections.
    Okada M; Minamishima Y
    Microbiol Immunol; 1987; 31(5):435-47. PubMed ID: 2443815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of latent cytomegalovirus infection: the macrophage as a virus-harboring cell.
    Hayashi K; Saze K; Uchida Y
    Microbiol Immunol; 1985; 29(7):625-34. PubMed ID: 3003544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of mouse cytomegalovirus infection during host-versus-graft reaction.
    Wu BC; Dowling JN; Armstrong JA; Ho M
    Science; 1975 Oct; 190(4209):56-8. PubMed ID: 170676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection.
    Balthesen M; Dreher L; Lucin P; Reddehase MJ
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2329-36. PubMed ID: 8077931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cell source, mouse strain, and immunosuppressive treatment on production of virulent and attenuated murine cytomegalovirus.
    Selgrade MK; Nedrud JG; Collier AM; Gardner DE
    Infect Immun; 1981 Sep; 33(3):840-7. PubMed ID: 6270000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cytomegalovirus infection following cardiac transplantation in a murine model.
    Rubin RH; Wilson EJ; Barrett LV; Medearis DN
    Transplantation; 1984 Mar; 37(3):306-10. PubMed ID: 6322391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo model for the acute, latent and reactivated phases of cytomegalovirus infection.
    Gönczöl E; Danczig E; Boldogh I; Tóth T; Váczi L
    Acta Microbiol Hung; 1985; 32(1):39-47. PubMed ID: 2994350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of latent murine cytomegalovirus in vivo and in vitro: a pathogenetic role for acute infection.
    Jordan MC; Takagi JL; Stevens JG
    J Infect Dis; 1982 May; 145(5):699-705. PubMed ID: 6281340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression reactivates and disseminates latent murine cytomegalovirus.
    Jordan MC; Shanley JD; Stevens JG
    J Gen Virol; 1977 Nov; 37(2):419-23. PubMed ID: 200714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The source of murine cytomegalovirus in mice receiving kidney allografts.
    Klotman ME; Starnes D; Hamilton JD
    J Infect Dis; 1985 Dec; 152(6):1192-6. PubMed ID: 2999256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine cytomegalovirus: reactivation in pregnancy.
    Gould JJ; Mims CA
    J Gen Virol; 1980 Dec; 51(Pt 2):397-400. PubMed ID: 6262441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of mouse cytomegalovirus nucleic acid in latently infected mice by in vitro enzymatic amplification.
    Klotman ME; Henry SC; Greene RC; Brazy PC; Klotman PE; Hamilton JD
    J Infect Dis; 1990 Feb; 161(2):220-5. PubMed ID: 2153738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine cytomegalovirus gene amplification and culture after submaxillary salivary gland biopsy.
    Schmader KE; Rahija RJ; Porter KR; Hamilton JD
    Lab Anim Sci; 1991 Oct; 41(5):396-400. PubMed ID: 1666135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of mouse cytomegalovirus in organs of white mice experimentally infected by natural route.
    Svobodová J; Blaskovic D; Hucková D
    Acta Virol; 1986 Nov; 30(6):515-8. PubMed ID: 2881473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice.
    Yuhasz SA; Dissette VB; Cook ML; Stevens JG
    Virology; 1994 Jul; 202(1):272-80. PubMed ID: 8009839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections.
    Mercer JA; Wiley CA; Spector DH
    J Virol; 1988 Mar; 62(3):987-97. PubMed ID: 2828694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive murine cytomegalovirus disease after termination of ganciclovir therapy in mice immunosuppressed by cyclophosphamide treatment.
    Smee DF; Burger RA; Coombs J; Huffman JH; Sidwell RW
    J Infect Dis; 1991 Nov; 164(5):958-61. PubMed ID: 1658160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection of laboratory rats with a new cytomegalo-like virus.
    Bruggeman CA; Debie WM; Grauls G; Majoor G; van Boven CP
    Arch Virol; 1983; 76(3):189-99. PubMed ID: 6307225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence characteristics of murine cytomegalovirus in cell and organ cultures.
    Jordan MC; Takagi JL
    Infect Immun; 1983 Aug; 41(2):841-3. PubMed ID: 6307886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.